Discover 1,664 paid clinical trials in Princeton, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,664
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
for
Non-Small Cell Lung Cancer
Location: East Brunswick NJ, New York NY, Fairfax VA,
Sponsor: Verastem, Inc.
Sex: All
Age: 18+
Code: NCT07659782
Phase2, Recruiting
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
for
Relapsed/Refractory Hematological Malignancies,
Location: East Brunswick NJ, Grand Rapids MI, Los Angeles CA
Sponsor: Ascentage Pharma Group Inc.
Sex: All
Age: 18+
Code: NCT07424833
Phase1, Recruiting
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
for
HER2-positive Breast Cancer, Breast Cancer
Location: East Brunswick NJ, New York NY, Newark NJ, Laurel MD,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07102381
Phase2, Recruiting
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: East Brunswick NJ, New Brunswick NJ, New York NY,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07621718
Phase3, Recruiting
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
for
ER+, HER 2- Breast Cancer, Non-small Cell Lung Cancer (NSCLC),
Location: East Brunswick NJ, Lake Success NY, Fairfax VA,
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18 - 70+
Code: NCT07540572
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
for
Systemic Lupus Erythematosus (With and Without Nephritis),
Location: East Brunswick NJ, New York NY, Baltimore MD, Montreal,
Sponsor: Allogene Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07085104
Phase1, Recruiting
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
Location: East Brunswick NJ, Hackensack NJ, Toronto, Ottawa,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT04728893
Phase2, Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for
Triple Negative Breast Cancer
Location: East Brunswick NJ, New Brunswick NJ, Flemington NJ,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT05633654
Phase3, Recruiting
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
for
Advanced Breast Cancer
Location: East Brunswick NJ, Brooklyn NY, New York NY, Mineola NY,
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06638307
Phase1, Recruiting
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
for
Relapsed or Refractory Multiple Myeloma
Location: East Brunswick NJ, Allentown PA, Lake Success NY,
Sponsor: Celgene
Sex: All
Age: 18+
Code: NCT05519085
Phase3, Recruiting
SLV-154 Treatment of Advanced Cancers
for
Advanced Cancer, Advanced Solid Tumor, Metastatic Cancer
Location: East Brunswick NJ, Philadelphia PA, New York NY,
Sponsor: Solve Therapeutics
Sex: All
Age: 12+
Code: NCT06771219
Phase1, Recruiting
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
for
Advanced Non-Small Cell Lung Cancer,
Location: East Brunswick NJ, Hackensack NJ, Teaneck NJ,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT04613596
Phase2, Phase3, Recruiting
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
for
Adenocarcinoma, Carcinoma, Pancreatic Ductal
Location: East Brunswick NJ, Morristown NJ, Shirley NY, Albany NY,
Sponsor: Corcept Therapeutics
Sex: All
Age: 18+
Code: NCT07259317
Phase2, Recruiting
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2